Pfizer Inc
PFE· NYSE
Released May 1, 2024, before the open
10-Q filed May 8, 2024, 38 days after period end · 0000078003-24-000107
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Revenue | $14.88B | $18.49B | $25.66B | $14.52B |
| Net Income | $3.12B | $5.54B | $7.86B | $4.88B |
| EPS Diluted |
Pfizer Inc · CIK 78003 · Engraved from SEC EDGAR
| $0.55 |
| $0.97 |
| $1.37 |
| $0.86 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.